The Pharmacological Effect and Mechanism of Lanthanum Hydroxide on Vascular Calcification Caused by Chronic Renal Failure Hyperphosphatemia

The Pharmacological Effect and Mechanism of Lanthanum Hydroxide on Vascular Calcification Caused by Chronic Renal Failure Hyperphosphatemia

ObjectiveThe present work aimed to explore the efficacy of lanthanum hydroxide in managing the vascular calcification induced by hyperphosphate in chronic renal failure (CRF) as well as the underlying mechanism.MethodsRats were randomly allocated to five groups: normal diet control, CKD hyperphospha...

Full description

Bibliographic Details
Main Authors:	Lulu Zhao, Shengnan Wang, Hong Liu, Xiaoli Du, Ren Bu, Bing Li, Ruilan Han, Jie Gao, Yang Liu, Jian Hao, Jianrong Zhao, Yan Meng, Gang Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	lanthanum hydroxide vascular calcification chronic renal failure hyperphosphatemia pharmacological effect mechanism
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.639127/full

Similar Items

Safety and effectiveness of lanthanum carbonate for hyperphosphatemia in chronic kidney disease (CKD) patients: a meta-analysis
by: Lijuan Zhao, et al.
Published: (2021-01-01)

Lanthanum hydroxide protects kidney through gut microbiota in a rat model of chronic kidney disease
by: Yuan Gao, et al.
Published: (2024-04-01)

Clinical and pharmacoeconomic profile of lanthanum carbonate treatment of hyperphosphataemia in chronic renal dialysis patients
by: Mario Eandi
Published: (2010-03-01)

RNA-seq analysis of extracellular vesicles from hyperphosphatemia-stimulated endothelial cells provides insight into the mechanism underlying vascular calcification
by: Zhong Peng, et al.
Published: (2022-05-01)

Effect of Lanthanum Carbonate on All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: a Meta-Analysis of Randomized Controlled Trials
by: Fang Wang, et al.
Published: (2018-03-01)

Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study
by: Parminder Nain, et al.
Published: (2023-02-01)

Elemental calcium intake associated with calcium acetate/calcium carbonate in the treatment of hyperphosphatemia
by: Rosamund J Wilson, et al.
Published: (2017-01-01)

Removal of Hazardous Oxyanion Pollutants by Lanthanum (Iii) Hydroxide and Lanthanum (III) - Loaded Ion Exchangers
by: Ahmed, Yehya M.
Published: (2004)

Vascular Calcification: An Important Understanding in Nephrology
by: Zununi Vahed S, et al.
Published: (2020-05-01)

Hyperphosphatemia: The risk factor for adverse outcome in maintenance hemodialysis patients
by: Petrović Dejan, et al.
Published: (2012-01-01)

The Key Role of Phosphate on Vascular Calcification
by: Mario Cozzolino, et al.
Published: (2019-04-01)

Inflammatory, Metabolic, and Coagulation Effects on Medial Arterial Calcification in Patients with Peripheral Arterial Disease
by: Jovana Nikolajević, et al.
Published: (2023-02-01)

Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis
by: Kentaro Watanabe, et al.
Published: (2020-01-01)

Clinical Evaluation of Niacin in Hemodialysis Patients with Hyperphosphatemia as Adjuvant to Calcium Carbonate
by: Rana Bahaa Mohammed, et al.
Published: (2020-09-01)

The Effect of Magnesium Oxide on Hyperphosphatemia in Female Hemodialysis Patients
by: Maryam Pakfetrat, et al.
Published: (2014-07-01)

Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis
by: Ju-Young Moon, et al.
Published: (2015-03-01)

Extracellular Vesicles As Mediators of Cardiovascular Calcification
by: Amirala Bakhshian Nik, et al.
Published: (2017-12-01)

The importance of nutritional intervention by dietitians for hyperphosphatemia in maintained hemodialysis patients
by: Yuka Kawate, et al.
Published: (2017-04-01)

Phosphate-Trapping Liposomes for Long-Term Management of Hyperphosphatemia
by: Chen Tzror-Azankot, et al.
Published: (2022-11-01)

Is there any link between hyperphosphatemia, hypoalbuminemia, and hypocalcemia with hospital outcomes in COVID-19 patients?
by: Atefeh Rezaeifar, et al.
Published: (2023-01-01)

Hyperphosphatemia in chronic kidney disease
by: S. A. Martynov, et al.
Published: (2019-10-01)

Correction of hyperphosphatemia in hemodialysis patients: 12-month findings from a randomized study
by: I.O. Dudar, et al.
Published: (2022-08-01)

Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients
by: Qian Zeng, et al.
Published: (2023-12-01)

Calcium acetate versus calcium carbonate in the control of hyperphosphatemia in hemodialysis patients
by: Eufrônio José d'Almeida Filho, et al.
Published: (2000-11-01)

Genetic Evidence for a Causal Role of Serum Phosphate in Coronary Artery Calcification: The Rotterdam Study
by: Natalia Campos‐Obando, et al.
Published: (2022-08-01)

Aging‐related hyperphosphatemia impairs myogenic differentiation and enhances fibrosis in skeletal muscle
by: Patricia Sosa, et al.
Published: (2021-10-01)

Hyperphosphatemia and Outcomes in Critically Ill Patients: A Systematic Review and Meta-Analysis
by: Wen-He Zheng, et al.
Published: (2022-05-01)

Vascular Calcification in Chronic Kidney Disease: Diversity in the Vessel Wall
by: Prabhatchandra Dube, et al.
Published: (2021-04-01)

Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia
by: Frida Palafox-Serdán, et al.
Published: (2020-10-01)

Adesão e conhecimento sobre o tratamento da hiperfosfatemia de pacientes hiperfosfatêmicos em hemodiálise Adherence and knowledge about hyperphosphatemia treatment in hemodialysis patients with hyperphosphatemia
by: Fabiana B. Nerbass, et al.
Published: (2010-06-01)

Tri-functional lanthanum-based biochar for efficient phosphorus recovery, bacterial inhibition, and soil fertility enhancement
by: Xiuxiu Jia, et al.
Published: (2023-03-01)

Control of hyperphosphatemia in regular hemodialysis (HDx) patients by calcium acetate (CA) versus calcium carbonate (CC). A double blind crossover prospective study
by: U A A Sharaf EI Din, et al.
Published: (1999-05-01)

Hyperphosphatemia-Induced Oxidant/Antioxidant Imbalance Impairs Vascular Relaxation and Induces Inflammation and Fibrosis in Old Mice
by: Ana Asenjo-Bueno, et al.
Published: (2021-08-01)

Intensified treatment of hyperphosphatemia associated with reduction in parathyroid hormone in patients on maintenance hemodialysis
by: Lan Chen, et al.
Published: (2018-10-01)

Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor 23 and Klotho
by: L Yu Milovanova, et al.
Published: (2010-06-01)

Severe hyperphosphatemia and symptomatic hypocalcemia after bowel cleansing with oral sodium phosphate solution in a patient with postoperative hypoparathyroidism
by: Berker Dilek, et al.
Published: (2010-02-01)

Synthesis and spectroscopic studies of lanthanum(111) ketohhydrazone complexes /
by: 411877 Suhaila Borhamdin
Published: (2002)

Protein and Phosphate Intakes are Associated with Hyperphosphatemia in Hemodialysis Patients at Sanglah Hospital, Bali, Indonesia
by: Made Dyah Vismita Indramila Duarsa, et al.
Published: (2022-06-01)

Hyperphosphatemia and Cardiovascular Disease
by: Chao Zhou, et al.
Published: (2021-03-01)

Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis
by: Xueying Ding, et al.
Published: (2024-03-01)